247 related articles for article (PubMed ID: 32762091)
1. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies.
Koss DJ; Bondarevaite O; Adams S; Leite M; Giorgini F; Attems J; Outeiro TF
Brain Pathol; 2021 Jan; 31(1):120-132. PubMed ID: 32762091
[TBL] [Abstract][Full Text] [Related]
2. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases.
Koss DJ; Campesan S; Giorgini F; Outeiro TF
Mov Disord; 2021 Aug; 36(8):1744-1758. PubMed ID: 33939203
[TBL] [Abstract][Full Text] [Related]
4. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
[TBL] [Abstract][Full Text] [Related]
6. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.
Hodges K; Brewer SS; Labbé C; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; van Gerpen JA; Ertekin-Taner N; Kantarci K; Lowe VJ; Parisi JE; Savica R; Graff-Radford J; Jones DT; Knopman DS; Petersen RC; Murray ME; Graff-Radford NR; Ferman TJ; Dickson DW; Wszolek ZK; Boeve BF; Ross OA; Lorenzo-Betancor O
Neurobiol Aging; 2016 Sep; 45():107-108. PubMed ID: 27459931
[TBL] [Abstract][Full Text] [Related]
7. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
8. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
10. Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology.
Armstrong RA; Cairns NJ
Neurol Sci; 2009 Dec; 30(6):471-7. PubMed ID: 19768369
[TBL] [Abstract][Full Text] [Related]
11. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
14. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.
Howlett DR; Whitfield D; Johnson M; Attems J; O'Brien JT; Aarsland D; Lai MK; Lee JH; Chen C; Ballard C; Hortobágyi T; Francis PT
Brain Pathol; 2015 Jul; 25(4):401-8. PubMed ID: 25103200
[TBL] [Abstract][Full Text] [Related]
15. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
16. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
[TBL] [Abstract][Full Text] [Related]
17. Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases.
Moors TE; Morella ML; Bertran-Cobo C; Geut H; Udayar V; Timmermans-Huisman E; Ingrassia AMT; Brevé JJP; Bol JGJM; Bonifati V; Jagasia R; van de Berg WDJ
Acta Neuropathol; 2024 Apr; 147(1):67. PubMed ID: 38581586
[TBL] [Abstract][Full Text] [Related]
18. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
19. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
20. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
